JP2023543132A5 - - Google Patents
Info
- Publication number
- JP2023543132A5 JP2023543132A5 JP2023513678A JP2023513678A JP2023543132A5 JP 2023543132 A5 JP2023543132 A5 JP 2023543132A5 JP 2023513678 A JP2023513678 A JP 2023513678A JP 2023513678 A JP2023513678 A JP 2023513678A JP 2023543132 A5 JP2023543132 A5 JP 2023543132A5
- Authority
- JP
- Japan
- Prior art keywords
- cyclodextrin
- hydroxypropyl
- individual
- amount
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063071243P | 2020-08-27 | 2020-08-27 | |
| US63/071,243 | 2020-08-27 | ||
| PCT/US2021/048075 WO2022047244A1 (en) | 2020-08-27 | 2021-08-27 | Methods for the prevention of cholesterol crystal embolization with cyclodextrins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543132A JP2023543132A (ja) | 2023-10-13 |
| JP2023543132A5 true JP2023543132A5 (https=) | 2024-08-27 |
Family
ID=80352440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513678A Pending JP2023543132A (ja) | 2020-08-27 | 2021-08-27 | シクロデキストリンによるコレステロール結晶塞栓症の予防方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230302042A1 (https=) |
| EP (1) | EP4203973A4 (https=) |
| JP (1) | JP2023543132A (https=) |
| KR (1) | KR20230096976A (https=) |
| CN (1) | CN116635007A (https=) |
| AU (1) | AU2021331485A1 (https=) |
| BR (1) | BR112023003490A2 (https=) |
| CA (1) | CA3190764A1 (https=) |
| IL (1) | IL300881A (https=) |
| MX (1) | MX2023002420A (https=) |
| WO (1) | WO2022047244A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4877778A (en) * | 1987-07-01 | 1989-10-31 | The Children's Medical Center Corporation | Method of enhancing lipophile transport using cyclodextrin derivatives |
| MX371073B (es) * | 2012-04-13 | 2020-01-15 | L&F Res Llc | Método para utilizar ciclodextrina. |
-
2021
- 2021-08-27 MX MX2023002420A patent/MX2023002420A/es unknown
- 2021-08-27 WO PCT/US2021/048075 patent/WO2022047244A1/en not_active Ceased
- 2021-08-27 KR KR1020237010391A patent/KR20230096976A/ko not_active Withdrawn
- 2021-08-27 US US18/043,009 patent/US20230302042A1/en active Pending
- 2021-08-27 BR BR112023003490A patent/BR112023003490A2/pt not_active Application Discontinuation
- 2021-08-27 IL IL300881A patent/IL300881A/en unknown
- 2021-08-27 CA CA3190764A patent/CA3190764A1/en active Pending
- 2021-08-27 JP JP2023513678A patent/JP2023543132A/ja active Pending
- 2021-08-27 CN CN202180066571.3A patent/CN116635007A/zh active Pending
- 2021-08-27 EP EP21862878.2A patent/EP4203973A4/en active Pending
- 2021-08-27 AU AU2021331485A patent/AU2021331485A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1917866B (zh) | 曲前列环素或它的衍生物，或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途 | |
| CA2684450C (en) | Progesterone antagonist and selective progesterone modulator in the treatment of excessive uterine bleeding | |
| Butler et al. | Amphotericin B renal toxicity in the dog | |
| JP2002520287A (ja) | 黄斑変性における血管新生の予防的治療 | |
| JP2023543133A5 (https=) | ||
| JP2024519629A (ja) | 血管新生性眼疾患の治療のための長期の高用量ｖｅｇｆアンタゴニストレジメン | |
| JP7835735B2 (ja) | シクロデキストリンによるコレステロール結晶塞栓症の治療方法 | |
| Wacker et al. | Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major | |
| JP2023543132A5 (https=) | ||
| JP2000026300A (ja) | 血管内皮細胞保護医薬組成物 | |
| JP2024026871A (ja) | 慢性便秘症を治療するための医薬組成物 | |
| JP2018108993A (ja) | 注腸剤 | |
| Rivera-Gonzalez et al. | Use of sublingual nitrates for management of limb ischemia secondary to inadvertent intra-arterial buprenorphine/naloxone (Suboxone®) film injection | |
| Wizemann et al. | Biphasic action of prostacyclin on intraocular pressure | |
| JP2025508660A5 (https=) | ||
| CN107854580A (zh) | 一种降脂的中药组合物及其制备方法 | |
| WO2017015691A1 (de) | Konzentrat enthaltend alprostadil | |
| KR101768809B1 (ko) | 덱사메타손 및 글리벤클라마이드를 포함하는 뇌졸중의 예방 또는 치료용 약학적 조성물 | |
| HK40073572B (zh) | 酒精性肝炎的治疗 | |
| JP2023543132A (ja) | シクロデキストリンによるコレステロール結晶塞栓症の予防方法 | |
| JPS5920221A (ja) | レイノ−症状の改善・治療剤 | |
| US20070173479A1 (en) | Methods Using Sulodexide for the Treatment of Bladder Disease | |
| Shumaker | Issues in Renal Nutrition | |
| Sessions | Intensive giycemic controi associated with increased mortaiity in high-risi< patients | |
| Gianni Belcaro et al. | Arteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E |